Nallamothu Brahmajee K, Bates Eric R, Herrin Jeph, Wang Yongfei, Bradley Elizabeth H, Krumholz Harlan M
Health Services Research and Development Center for Excellence, Ann Arbor Veterans Affairs Medical Center, Ann Arbor, Mich, USA.
Circulation. 2005 Feb 15;111(6):761-7. doi: 10.1161/01.CIR.0000155258.44268.F8. Epub 2005 Feb 7.
Treatment delays in patients with ST-segment-elevation myocardial infarction (STEMI) transferred for primary percutaneous coronary intervention (PCI) may decrease the advantage of this strategy over on-site fibrinolytic therapy that has been demonstrated in recent clinical trials. Accordingly, we sought to describe patterns of times to treatment in patients undergoing interhospital transfer for primary PCI in the United States.
We analyzed patients with STEMI undergoing interhospital transfer for primary PCI between January 1999 and December 2002 in the National Registry of Myocardial Infarction. The primary outcome was "total" door-to-balloon time measured from time of arrival at the initial hospital to time of balloon inflation at the PCI hospital. Multivariable hierarchical models were used to assess the relationship of total door-to-balloon time with patient and hospital characteristics. Among 4278 patients transferred for primary PCI at 419 hospitals, the median total door-to-balloon time was 180 minutes, with only 4.2% of patients treated within 90 minutes, the benchmark recommended by national quality guidelines. Comorbid conditions, absence of chest pain, delayed presentation after symptom onset, less specific ECG findings, and hospital presentation during off-hours were associated with longer total door-to-balloon times. Patients at teaching hospitals in rural areas also had significantly longer times to treatment.
Total door-to-balloon times for transfer patients undergoing primary PCI in the United States rarely achieve guideline-recommended benchmarks, and current decision making should take these times into account. For the full benefits of primary PCI to be realized in transfer patients, improved systems are urgently needed to minimize total door-to-balloon times.
接受直接经皮冠状动脉介入治疗(PCI)转运的ST段抬高型心肌梗死(STEMI)患者的治疗延迟可能会降低该策略相对于近期临床试验中已证实的现场溶栓治疗的优势。因此,我们试图描述在美国接受院间转运进行直接PCI治疗的患者的治疗时间模式。
我们分析了1999年1月至2002年12月期间在国家心肌梗死注册中心接受院间转运进行直接PCI治疗的STEMI患者。主要结局是“总”门球时间,即从到达初始医院到PCI医院球囊扩张的时间。使用多变量分层模型评估总门球时间与患者及医院特征之间的关系。在419家医院接受直接PCI转运的4278例患者中,总门球时间的中位数为180分钟,只有4.2%的患者在90分钟内接受治疗,这是国家质量指南推荐的基准。合并症、无胸痛、症状发作后就诊延迟、心电图表现不典型以及非工作时间到院就诊与总门球时间延长有关。农村地区教学医院的患者治疗时间也明显更长。
在美国,接受直接PCI治疗的转运患者的总门球时间很少达到指南推荐的基准,当前的决策应考虑这些时间。为了使转运患者充分受益于直接PCI,迫切需要改进系统以尽量缩短总门球时间。